| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Common Stock | Options Exercise | $79,973 | +888 | +13% | $90.06 | 7,524 | 07 Feb 2024 | Direct | F1 |
| transaction | RGA | Common Stock | Tax liability | $87,378 | -517 | -6.9% | $169.01 | 7,007 | 07 Feb 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Stock Appreciation Right (right to purchase) 2015 | Options Exercise | $0 | -1,902 | -100% | $0.000000* | 0 | 07 Feb 2024 | Common Stock | 1,902 | $90.06 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents (i) 1,014 shares sold to pay the exercise price the purchase of Common Stock, and (ii) 517 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 371 shares. |
| F2 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |